Escherichia coli enteritis historical perspective
|
Escherichia coli enteritis Microchapters |
|
Differentiating Escherichia coli enteritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Escherichia coli enteritis historical perspective On the Web |
|
American Roentgen Ray Society Images of Escherichia coli enteritis historical perspective |
|
Escherichia coli enteritis historical perspective in the news |
|
Risk calculators and risk factors for Escherichia coli enteritis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Serge Korjian M.D., Yazan Daaboul, M.D.
Overview
Theodor Escherich, a German physician, was the first to grow cultures of E. coli in 1885. The first pathogenic E. coli strain described was enteropathogenic E. coli (EPEC). The infection was reported in 1945 following outbreaks of infant diarrhea in the United Kingdom.[1]
Historical Perspective
- Theodor Escherich, a German physician, was the first to grow cultures of E. coli in 1885.
- Prior to reports of pathogenicity, all strains of E. coli were first thought to be part of the normal flora. The first pathogenic E. coli strain described was enteropathogenic E. coli (EPEC). The infection was reported in 1945 following outbreaks of infant diarrhea in the United Kingdom.[1]
- The majority of advances in understanding the pathogenesis of enteropathogenic E. coli infection were made in the late 1970s / early 1980s.[2]
- Subsequently, other pathogenic E. coli strains were described in the early 1980s: EHEC (enterohemorrhagic E. coli)then ETEC (enterotoxicogenic E. coli) and then followed by EIEC (enteroinvasive E. coli) and finally DAEC (diffusely adherent E. coli).[2]
References
- ↑ 1.0 1.1 Bray, J (1945). "Isolation of antigenically homogeneous strains of Bacterium coli neapolitanum from summer diarrhoea of infants". J of Pathol Bacteriol. 57 (2): 239–47.
|access-date=requires|url=(help) - ↑ 2.0 2.1 Pennington TH (2014). "E. coli O157 outbreaks in the United Kingdom: past, present, and future". Infect Drug Resist. 7: 211–22. doi:10.2147/IDR.S49081. PMC 4149388. PMID 25187729.